The hospitalization rate and clinical characteristics of mucormycosis prior and during COVID-19 pandemic: A single-center study

Conclusions: In high-risk patients, especially diabetics, special care to avoid the development of mucormycosis must be taken into account in patients with SARS-COV-2 infection considered for treatment with corticosteroids.

Source: The Journal of Infection in Developing Countries - June 29, 2023 Category: Infectious Diseases Authors: Mehrdad Estakhr, Zahra Ghotbi, Mahtab Rostamihosseinkhani, Etrat Hooshmandi, Masoud Janipour, Vahid Reza Ostovan, Nima Fadakar, Hanieh Bazrafshan, Zahra Bahrami, Abbas Rahimi-Jaberi, Maryam Poursadeghfard, Masoumeh Nazeri, Pariya Kouhi, Peyman Petramfar, Source Type: research